Proteome Sciences announced the completion of installation and setup of equipment in its new US laboratory in San Diego, California. and is therefore now fully operational. The laboratory uses the latest generation Orbitrap Ascend Tribrid mass spectrometry and automated sample preparation platforms that will extend the range of services offered to customers.

This new facility is based in one of the largest biotech hubs in the US - a hub which has had, collectively, investment of $17.2 billion and US National Institute of Health funding of $6 billion in 2022/23 - Proteome Sciences' Laboratory is well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes. By removing the need to ship samples internationally services are more attractive to customers from both Pharma and academia alike.